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Abstract
Experiments were conducted to identify and characterize the equine herpesvirus type 1 (EHV-1) UL11 homologous protein. At early-late
times after EHV-1 infection of Rk13 cells several proteins at an Mr of 8000 to 12,000 were detected using a UL11 protein-specific antiserum.
Particularly, an Mr of 11,000 protein was found abundantly in purified virions and could be assigned to the tegument fraction. As
demonstrated by confocal laser scanning microscopy, UL11 reactivity localized predominantly to the trans-Golgi network of infected cells,
but was also noted at the plasma membrane, specifically of transfected cells. Deletion of UL11 sequences in EHV-1 vaccine strain RacH
(H11) and in the virulent isolate RacL22 (L11) resulted in viruses that were able to replicate on noncomplementing cells. It was shown
in one-step growth kinetics on Rk13 cells that the reduction of intracellular and of extracellular virus titers caused by the absence of UL11
expression in either virus was somewhat variable, but approximately 10- to 20-fold. In contrast, a marked influence on the plaque phenotype
was noted, as mean maximal diameters of plaques were reduced to 23.2% (RacL22) or 34.7% (RacH) of parental virus plaques and as an
effect on the ability of RacH to cause syncytia upon infection was noted. It was therefore concluded that the EHV-1 UL11 product is not
essential for virus replication in Rk13 cells but is involved in cell-to-cell spread.
© 2003 Elsevier Science (USA). All rights reserved.
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INTRODUCTION
Equine herpesvirus type 1 (EHV-1), an important patho-
gen of horses, is a member of the subfamily Alphaherpes-
virinae (Allen and Bryans, 1986). The pathway of Alpha-
herpesvirus assembly has been subject of discussion for
some time and two main models were suggested (Roizman
and Knipe, 2001; Mettenleiter, 2002). Recent findings favor
that the maturation of most members of the subfamily in-
volved at least two distinct steps of tegumentation and
envelopment: Budding of newly formed capsids at the inner
nuclear membrane results in the acquisition of a primary
envelope that is then lost by fusion with the outer nuclear
membrane. Capsids are thus released into the cytoplasm and
become completed finally to mature virions by budding into
vesicles of the trans-Golgi network (TGN) (Mettenleiter,
2002). To allow efficient assembly, numerous herpesviral
structural proteins have to come together in an ordered
fashion at defined cellular compartments. Various Alpha-
herpesvirus gene products have been proposed to play some
role in egress, but as yet only few have been associated with
a definite function (Sun et al., 1996; Osterrieder et al., 1998;
Oettler et al., 2001; Roizman and Knipe, 2001; Mettenleiter,
2002). The understanding of assembly and egress is com-
plicated additionally by the fact that mechanisms can differ
not only between members of the subfamily but also be-
tween cell systems used (Baines et al., 1991; Baines and
Roizman, 1992; Fuchs et al., 1997). Furthermore, functions
of viral gene products can be connected to others or even
redundant in vitro, such that only deleting simultaneously
several genes might reveal a clear phenotype—a phenome-
non that has for example been reported for glycoproteins M,
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E, and I, that are all involved in secondary envelopment
(Brack et al., 1999; Seyboldt et al., 2000).
The herpes simplex virus 1 (HSV-1) UL11 protein is a
small, phosphorylated, palmitylated, and myristylated
virion protein, forming up to five bands in polyacrylamide
gels (MacLean et al., 1989; Baines et al., 1995; Loomis et
al., 2001). The UL11 product is suggested to reside in the
viral tegument and is associated with membranes of infected
cells, although the structural prerequisites for a transmem-
brane anchor are not given (MacLean et al., 1992). By
immune electron microscopic analyses UL11 reactivity was
found in various undefined cytoplasmic ribbon-like struc-
tures or membranes but especially at the inner nuclear
membrane and also in distinct sites within the nucleus
(Baines et al., 1995). In contrast, when expressed in the
absence of other HSV-1 proteins, the UL11 protein has been
demonstrated to be targeted to the Golgi apparatus, exhib-
iting highly dynamic membrane-trafficking properties. The
protein was shown to recycle from the plasma membrane to
Golgi membranes mediated by a conserved acidic amino
acid cluster. The relevance of myristylation and in particular
palmitylation for a strong association with cellular mem-
branes and for a specific localization to the Golgi apparatus
has been emphasized. As the Golgi region represents the
compartment of secondary envelopment, a role of the UL11
protein in virus assembly has been discussed (Bowzard et
al., 2000; Loomis et al., 2001).
UL11-negative HSV-1 induce smaller plaques and show
reduced growth in vitro, reaching a final yield 5- to 20-fold
(MacLean et al., 1992) or 30- to 280-fold less than parental
viruses relative to the cell systems used (Baines and Roiz-
man, 1992). In Vero cells, as analyzed by Baines and Roiz-
man (1992), a markedly delayed and reduced production
(over 1000-fold) of extracellular virus titers was found,
corroborating their electron microscopic data showing cap-
sids accumulating at the inner nuclear membrane and in-
creasing numbers of naked particles in the cytoplasm. The
HSV-1 UL11 is therefore thought to influence budding at
the inner nuclear membrane and to facilitate transport of
virions into the extracellular space (Baines and Roizman,
1992). As UL11 reactivity was also found within distinct
areas of the nucleus, again more as yet unidentified func-
tions were suggested (Baines et al., 1995). Generally, the
gene products of the UL11 homologs of the Alphaherpes-
virinae exhibit low- sequence similarity, but the myristyla-
tion consensus sites and the presence of several cysteine
residues in the amino-terminal regions of the polypeptides
appear to be highly conserved and might indicate a common
function of the UL11 homologs (Davison and Scott, 1986;
Dijkstra et al., 1997; Telford et al., 1998; Osterrieder, 1999;
Bowzard et al., 2000). So far, only the function of the
HSV-1 UL11 protein has been investigated and discussed.
In this study, experiments were conducted to identify and
analyze the EHV-1 UL11 homologous protein. Using a
rabbit antiserum, several UL11 products were identified in
infected as well as in transfected cells. The EHV-1 UL11
protein was abundantly detected within the tegument frac-
tion of virions and shown to colocalize mainly with the
trans-Golgi network of EHV-1-infected cells. The function
of the protein was investigated after generating UL11 dele-
tions in EHV-1 strains RacL22 and RacH. RacH does ex-
hibit a more pronounced syncytial phenotype in cell culture
than its low-passage derivative RacL22 (Neubauer et al.,
1997) and therefore enabled us to assess a putative influence
of the UL11 product on syncytia formation. Functional
analysis revealed an impact, albeit minor, of the UL11
deletion on virus replication in cell culture and a prominent
decrease in plaque size, suggesting a role in cell-to-cell
spread of viruses.
RESULTS
Identification of the EHV-1 UL11 homologous protein
To identify the product of the UL11 homologous EHV-1
open reading frame (gene 51), an anti-UL11 serum was
generated by immunizing rabbits against a purified UL11-
mycHis fusion protein. The specificity of the anti-UL11
serum was ascertained (e.g., Fig. 1A, Fig. 3A) and the
reagent then used in Western blot analyses of lysates of
RacH or RacL22-infected Rk13 or Edmin337 cells. In the
following series of experiments mostly the data obtained
using EHV-1 wild-type strain RacL22 on Rk13 cells are
shown. After separation of samples by 16.5% Tris–Tricine–
polyacrylamide gel electrophoresis (PAGE), the UL11 an-
tiserum bound specifically to several polypeptides in the
range of Mrs 8000 to 12,000. In time-course experiments
expression kinetics of the UL11 products were compared to
that of the well-characterized EHV-1 glycoprotein B (gB).
Similar to gB expression (Fig. 1B) UL11 specific reactivity
was detected as early as 5 h postinfection (p.i.), and its
intensity increased until late in infection (Fig. 1C). At least
four different UL11 species were noted, the most prominent
of which running at an Mr of 11,000 (Figs. 1A and 1C).
When de novo viral DNA synthesis was inhibited by the
presence of 0.5 to 1.0 mg of phosphono acetic acid (PAA)
per milliliter of cell-culture medium, the expression of
UL11 products was reduced but not completely precluded,
again paralleling the expression kinetics of the early-late gB
(data not shown). It was thus confirmed that the EHV-1
UL11 products belonged into the early-late class of protein
expression.
The EHV-1 UL11 protein is tegument associated in
extracellular virions
A strong UL11-specific signal was observed in Western
blot analysis of EHV-1 virions that had been purified from
supernatants of infected cells (Fig. 2A, 15% Tris–Glycine
PAGE). The purity of all preparations and the integrity of
virions had been controlled by electron microscopy (data
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not shown) and on parallel blots using anti-gB mAb 3F6
(Fig. 2A), taking advantage of the fact that only the fully
processed form of gB is included into virus particles (Sul-
livan et al., 1989), or the anti-UL34 serum (Fig. 2B), using
its reactivity with intracellular but not extracellular virions
(Neubauer et al., 2002). To address the localization of the
UL11 protein within virion structures, viral envelopes were
separated from capsids after incubation with 1% Triton
X-100 and both fractions were analyzed individually by
Western blot. The major capsid protein (MCP) was detected
only in the capsid-enriched pellet and the envelope protein
gB in the envelope containing supernatant, whereas a sim-
ilar intensity of UL11 reactivity was revealed in either
sample (Fig. 2A). The strict separation of reactivity in
control blots and the presence of UL11 in both virion
fractions suggested a classification as a tegument protein of
EHV-1. As obviously 15% Tris–Glycine PAGE does not
resolve the different UL11 species (Fig. 2A), purified virus
particles were probed in parallel after 16.5% Tris–Tricine
PAGE and the exact banding pattern of UL11 reactivity in
virions was determined. As shown in Fig. 2B mainly the Mr
11,000 form of UL11 was detected accompanied by a less
intense protein at an Mr of 20,500 (Fig. 2B). As all samples
have always been heat denatured, infected cells as well as
purified virions, the Mr 20,500 protein species could reflect
very stable higher order structures of either UL11 products
alone or complex formation of UL11 with another viral
protein. This interaction could theoretically also be medi-
ated by putative fatty acid modifications. The Mr 20,500
band corresponded in size to formation of UL11 ho-
modimers, but further experiments will be necessary to
understand the composition of this species after all.
Subcellular localization of the EHV-1 UL11 protein
Although the overall homology of the known herpesviral
UL11 polypeptides is low, encoding for myristylation con-
sensus sequences and for cysteine residues that could serve
for palmitylation appears to be conserved. The HSV-1
UL11 protein has been shown to indeed be myristylated and
palmitylated (MacLean et al., 1989; Loomis et al., 2001).
Accordingly, the EHV-1 UL11 sequence carries corre-
sponding motifs and no features are found within the 74
amino acid polypeptide, allowing the prediction of a puta-
tive transmembrane anchor. If the protein was membrane
associated in infected or transfected cells, this should then
be mediated by myristyl and palmityl anchoring or interac-
tion. To determine the subcellular localization of the EHV-1
UL11 protein, RacL22- and un-infected Rk13 cells were
separated into fractions, containing either nucleic, membra-
nous, or soluble cytoplasmic components (Bogner et al.,
1992). In Western blot analysis of these fractions UL11
reactivity was discovered principally with cellular mem-
branes, just like the integral membrane protein gB, and both
were found to a lesser extend in the nucleic fraction (data
not shown). To analyze further the distribution of the UL11
Fig. 1. Western blot analysis of Rk13 cells that were infected at an m.o.i. of 3 with RacL22 or the UL11-negative virus L11. Cells were lysed at the given
times after infection, subjected to 12% Tris–Glycine PAGE (B) or to 16.5% Tris–Tricine PAGE (A, C). Blots were incubated with the anti-gB mAb 3F6 (B)
or the anti-UL11 antibody (A, C). The arrows emphasize the four UL11 species observed frequently (A). Sizes of the prestained precision molecular weight
marker (Bio-Rad) are indicated in thousands.
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product, Rk13 cells expressing UL11 at different times p.i.
(RacL22) and cells infected with the UL11-negative virus
L11 (see below) were subjected to indirect immunofluo-
rescence analysis, using the anti-UL11 serum and an Axio-
scope (Fig. 3A, green fluorescence). Since these initial tests
indicated a UL11-specific cytoplasmic staining pattern in
infected cells, other experiments were conducted to identify
the compartment of enhanced UL11 presence. As shown in
Fig. 3B, confocal laser scanning microscopic analysis of
Rk13 cells (9 h p.i.), that were simultaneously stained for
the trans-Golgi network marker protein -adaptin and for
the UL11 protein, suggested a specific concentration of
UL11 reactivity in the area of the TGN. In Rk13 or Cos7
cells transfected with either UL11-expression plasmid pC11
or pC11myc the localization to the TGN region was con-
served, but a more diffuse pattern was noted. An example of
pC11-transfected Rk13 cells is depicted (Fig. 3C), demon-
strating that UL11 reactivity was observed throughout cells
and somewhat concentrated at the plasma membrane. The
fluorescence pattern was similar after transfection of either
plasmid into either cell line, but appeared to be relative to
the amount of UL11 protein expressed in the individual
cell—the brighter the fluorescence, the less TGN specific.
As the current model of EHV-1 egress indicates a final
assembly of virus particles by budding into vesicles of the
Golgi area, the enhanced presence of the UL11 protein in
this area could either simply reflect the necessity to pile up
for incorporation into particles or point out a function of the
UL11 protein at this process.
Generation of UL11-negative RacL22 and RacH
To investigate the function of the UL11 protein in the
replication cycle of EHV-1 strains RacL22 and RacH,
67.4% of UL11 sequences each were replaced by the Esch-
erichia coli LacZ cassette taken out of plasmid pTT264A
(Mettenleiter and Rauh, 1990). As the UL12 homologous
ORF partially overlaps with the UL11 ORF (Fig. 4B),
sequences encoding for aa 1 to 24 of the UL11 polypeptide
had to be left intact (Fig. 4C). To ensure additionally correct
Fig. 2. Western blot analysis of RacL22 virions and of subviral fractions. (A) Virions purified from supernatants of RacL22-infected cells were incubated
in 1% Triton X-100 and then separated into a pellet and a supernatant fraction. Parallel blots were reacted with the anti-UL11 serum (15% Tris–Glycine
PAGE), with anti-gB mAb 3F6 or with mAb ZB4, directed against the EHV-1 major capsid protein (MCP; 12% Tris–Glycine PAGE). (B) UL11 reactivity
of purified virions was compared to that of lysates of RacL22-infected cells (14h p.i.) after 16.5% Tris–Tricine PAGE. The same samples were assayed for
UL34 reactivity after 12% Tris–Glycine PAGE. Sizes of a precision molecular weight marker (Bio-Rad) are indicated in thousands.
26 C. Schimmer, A. Neubauer / Virology 308 (2003) 23–36
27C. Schimmer, A. Neubauer / Virology 308 (2003) 23–36
termination of the UL14 to UL12 transcripts, that all do
coterminate with the UL11 transcript, extra polyadenylation
signal sequences were inserted between the stop codon of
UL12 and the marker gene cassette (Fig. 4C). The adjacent
transcripts should thus only be minimally changed, i.e.,
shortened by 48 nucleotides. Recombination was achieved
in Rk13 cells after cotransfection of plasmid p11LacZ
(Fig. 4C) with DNA of either RacH or RacL22. Virus
progeny was purified to homogeneity and analyzed by
Southern blot. The genotypes of the deletion mutants H11
and L11 as well as of the additionally generated, respec-
tive repaired viruses H11R and L11R, were compared to
the parental viruses RacH and RacL22 and confirmed using
probes specific for the LacZ cassette and for the viral frag-
ment, taken from plasmid pBH3.1 (Fig. 4B; data not
shown).
The EHV-1 UL11 protein is involved in cell-to-cell spread
Several experiments were conducted comparing proper-
ties of the different generated recombinant viruses to that of
parental viruses. First, Rk13 cells infected with RacL22,
L11, L11R, RacH, H11, or H11R were lysed 14 h p.i.
and expression of UL11 and of other early-late proteins was
judged by Western blot analysis. As shown in Fig. 5, no
UL11 specific reactivity at all was found in Rk13 cells
infected with the UL11-deleted EHV-1. These results al-
lowed the conclusion that the mutated viruses did not syn-
thesize any detectable aberrant or truncated UL11 product.
Moreover, other structural proteins, such as gB, gD, and
gM, were noted at similar levels, no matter whether UL11
was present or not. Apparently, a comparable amount of
cells had been infected initially and viral gene products
were produced efficiently. In a next step, kinetics of virus
growth were assessed. To this end, confluent monolayers of
Rk13 cells were infected at an m.o.i. of 3-5 and at different
times p.i. virus titers of supernatants (extracellular) and of
infected cells (intracellular) were determined independently
(Fig. 6). As expected, growth kinetics of the rescuant vi-
ruses L11R or H11R were virtually undistinguishable
from those of the parental viruses RacL22 and RacH. In
contrast, both UL11 negative viruses replicated constantly
to slightly reduced levels. The maximum reductions in virus
titers were detected in kinetics of extracellular RacH infec-
tivity (83-fold at 12 h p.i.). Titer decrease in RacL22 kinet-
ics never exceeded 25-fold (L11 to L11R at 9 h p.i.,
Fig. 3. Rk13 cells grown on glass coverslips were either infected with EHV-1 strain RacL22, the UL11 negative virus L11 (A, B), or transfected with
plasmid pC11 (C) and acetone-fixed. Times of fixation are given in A, whereas cells were analyzed at 9 h p.i. or at 48 h post transfection in B and C,
respectively. The UL11 protein was visualized using the anti-UL11 serum followed by an anti-rabbit Alexa 488 secondary antibody (green). The EHV-1
glycoprotein 2, detected with mAb 3B12 (A), or the trans-Golgi marker protein -adaptin, detected with an anti--adaptin mAb (Sigma) (B), were visualized
by the Alexa 546 secondary antibody (red). Blue fluorescence (A) was caused by DAPI staining of nuclei of L11-infected Rk13 cells. Cells were either
analyzed by conventional microscopy (A) or by confocal laser scanning microscopy (B, C). Pictures were digitally processed.
Fig. 4. (A) The BamHI map of EHV-1 strain RacL22 is illustrated. (B) The depicted BamHI-HindIII fragment contains the EHV-1 open reading frames 51
and 52 that are homologous to UL11 and UL10. The structure of the region and sites of primers for the amplification of UL11 flanking regions are shown.
(C) The construction of plasmid p11LacZ that was used for the generation of H11 and L11 is described under Materials and Methods. Restriction sites
are as follows: BamHI, B; HindIII, H; EcoRI, E; PstI, P; KpnI, K; SalI,-S.
28 C. Schimmer, A. Neubauer / Virology 308 (2003) 23–36
extracellular) and mostly ranged between 5- and 20-fold.
Likewise, the relation of virus yields did not change mark-
edly when lower m.o.i. (0.1 or 0.01) was used for infection.
The reduction in titers of UL11 negative viruses compared
to wild-type viruses was then noted to be between 1.2- and
20-fold (tested at 15 h p.i., data not shown). It was deduced
that neither virus suffered a severe growth defect after
deleting UL11 expression. Then, diameters and phenotypes
of RacL22-, L11-, L11R-, RacH-, H11-, or H11R-
induced plaques were analyzed on Rk13 cells, and repre-
sentative plaques are depicted in Fig. 7B. Maximal diame-
ters of 150 plaques each were measured, means calculated,
and results of parental viruses, i.e., RacH and RacL22, were
set to 100%, respectively. As graphically demonstrated in
Fig. 7A, maximal plaque diameters were drastically reduced
for both UL11-deleted viruses. Without UL11 expression
plaques reached only 23.2% (RacL22) or 34.7% (RacH) of
maximal diameters of parental plaques, whereas the plaque
size of the rescuant viruses corresponded well to wild-type.
When plaques were analyzed on cell-line 51D3 that consti-
tutively expresses a UL11-mycHis fusion protein, virtually
no differences were observed between parental plaques and
plaques of L11 and H11, underlining that the reported
phenotype was solely due to the deletion of UL11 sequences
and not to alterations of adjacent transcripts (Fig. 7A,
51D3). Taken together, both UL11-deletion mutants repli-
cated quite efficiently in Rk13 cells, but when infection was
directed from cell-to-cell, the deletion of UL11 resulted in a
marked disadvantage of the recombinant viruses. In the next
series of experiments, Rk13 cells were infected with RacH,
H11, or H11R at an m.o.i. of 1. At 14 h p.i. cells were
fixed, scraped off the support, pelleted, and embedded.
Semithin sections of cell pellets were stained by Toluidine
blue and the phenotypes of un-infected and infected cells
were compared. To demonstrate specific and comparable
EHV-1 infection of cells, parallel samples were infected
accordingly but then fixed and processed by indirect immu-
nofluorescence analysis (IIF), using anti-gp2 mAb 3B12
Fig. 5. Western blot analysis of expression of several early-late proteins in Rk13 cells infected with RacH, H11, H11R, RacL22, L11, or L11R. Blots
were probed with the anti-UL11 serum, anti-gB mAb 3F6, anti-gM mAb B8, or the anti-gD-19mer serum. Molecular weight marker sizes are indicated in
thousands (Biolabs).
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(Meyer and Hu¨bert, 1988). In Fig. 8 pictures of IIF-pro-
cessed cells are given next to examples of the respective
semithin sections. In RacH- or H11R-infected Rk13 cells
numerous large multinucleated cells were evident when
stained by IIF and especially in semithin sections. However,
after infection with H11—although cells clearly showed
all typical signs of infection and expressed gp2 to high
levels—rarely more than one nucleus accumulated per cell.
Over 1000 nuclei each were counted in pictures of semithin
sections, indicating that up to 10% of RacH-infected Rk13
cells carried three or more nuclei, whereas none such cells
were found after H11 infection. Because these results
somewhat implicated an influence of the UL11 protein on
RacH-induced membrane fusion events and as UL11 is a
virion component, albeit of the tegument, the possibility of
an effect on virus entry kinetics was also assessed. But no
delay in virus penetration of H11 compared to RacH could
be observed (data not shown). Taken together, it was shown
in this study that the deletion of the UL11 homologous gene
51 from EHV-1 strains RacL22 and RacH led to a minor
defect in overall virus replication in cell culture and espe-
cially to a prominent decrease in cell-to-cell fusion and the
spreading of infectivity to neighboring cells.
Discussion
In this article, data are presented indicating that the UL11
homolog of equine herpesvirus 1 is an early-late protein,
which is abundantly found in extracellular virions. It was
also shown that the EHV-1 UL11 protein localizes to cel-
lular membranes, specifically to the TGN region of infected
cells. Through functional analysis of UL11-negative viruses
it was demonstrated that the EHV-1 UL11 homolog is not
essential for virus replication in cell culture, but that its
deletion has a remarkable effect on plaque sizes in Rk13
cells. Finally, an impact of deleting UL11 on the ability of
the EHV-1 strain RacH to fuse Rk13 cells was observed.
The EHV-1 UL11 ORF (gene 51) is predicted to encode an
Mr 8400 polypeptide. After 16.5% Tris–Tricine PAGE sev-
eral species between Mr 8000 and 12,000 were detected in
RacL22 as well as in RacH-infected cells, using an anti-
Fig. 6. Rk13 cells were infected at an m.o.i. of 3-5 of either RacH (A) or RacL22 (B) and their respective recombinant derivatives. Kinetics of virus growth
are depicted as virus titers determined in supernatants of infected cells and in infected cells. Shown are means of three independent experiments and standard
deviations are given above symbols as error bars.
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serum that was produced in rabbits against the complete
UL11 polypeptide. The addition of a mycHis-tag to the
carboxyl-terminus of the UL11 sequence resulted in an
impressive increase of the apparent Mr to an Mr between
13,000 and 18,000 (data not shown), indicating that gener-
ally changes in the UL11 polypeptide can have a remarkable
effect on its running properties in PAGE. It is therefore
difficult to assign the different species of UL11 reactivity
yet, other than that the polypeptide has to be somehow
modified. The minor species, that is running at an Mr of
about 8000, could stand for an unprocessed backbone of
UL11. Furthermore, the sequence of the EHV-1 UL11 ho-
molog does carry a conserved myristylation consensus se-
quence (M-G-X-X-X-S/T) (Resh, 1999), as has been shown
to be used in the HSV-1 homologous protein (MacLean et
al., 1992). If myristylation occurred in EHV-1 also, this
could explain for some cotranslational alteration in the run-
ning profile of the polypeptide. Similarly, palmitylation and
phosphorylation that also affect the HSV-1 protein
(MacLean et al., 1989; Loomis et al., 2001) could change
the apparent Mr of the EHV-1 UL11 polypeptide. One
species at an Mr of 11,000 was always particularly promi-
nent and might therefore correspond to a mature and func-
tionally important form of the UL11 products. By analysis
of different cell fractions and by indirect immunofluores-
cence, an association could be demonstrated between the
EHV-1 UL11 homolog and cellular membranes, and the
UL11 protein was shown to accumulate in the region of the
trans-Golgi network of infected cells. Surprisingly, when
UL11 was expressed alone, the specific fluorescence was
found to be more dispersed throughout the cell, no matter
whether a mycHis-tag had been added or not. Moreover, the
pattern of fluorescence appeared to be somewhat relative to
the amount of protein expressed in the respective cell. Cells
exhibiting a bright UL11 fluorescence also stained markedly
in structures other than the TGN region, especially in the
area of the cell-surface membrane. In these cells, an over-
flow of Golgi retention or retrieval mechanisms that have
been demonstrated to be responsible for the localization of
the HSV-1 homolog might occur. Of course other factors or
products of viral infection might also be involved in con-
centrating the UL11 protein within the TGN region. It is
Fig. 7. Confluent monolayers of Rk13 or 51D3 cells in six-well plates were infected with RacH, H11, H11R, RacL22, L11, or L11R, using 50 PFU,
respectively. (A) At Day 3 p.i., maximal diameters of 150 plaques each were measured and average plaque sizes are given in percentages. Plaque diameters
of RacH and RacL22 on the respective cell line were set at 100% separately. Standard deviations are given as error bars. (B) Infected foci were analyzed
in an Axiovert (Magnification: 100; Zeiss, Germany) after IIF staining with anti-gB mAb 4B6. Pictures were scanned and digitally processed.
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Fig. 8. Rk13 cells were infected with RacH, H11, or H11R at an m.o.i. of 1. Fourteen hours p.i. cells were fixed and embedded, and un-infected control
cells were treated accordingly. Toluidine blue stained semithin sections of cells and parallel samples on glass coverslips that were stained by IIF with anti-gp2
mAb 3B12 were compared in an Axioscope (Zeiss, Germany). Pictures were taken digitally and processed. Bars represent 10 m in the left and 100 m in
the right panels.
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interesting to note that in contrast the HSV-1 UL11 protein
strongly accumulates in the Golgi region when expressed
alone, but is distributed differently during viral infection
(Baines et al., 1995; Loomis et al., 2001).
Investigation of two independent UL11-deleted EHV-1
revealed that UL11 expression does not have a major impact
on EHV-1 replication in Rk13 cells. Virus titers of UL11-
deleted viruses were reduced slightly but constantly
throughout all experiments. As the UL11 protein was shown
to be a component of EHV-1 virions and to be synthesized
at early-late times after infection, a role either in very early
events of infection or in some step in virus maturation and
egress has to be assumed. The HSV-1 homologous protein
facilitates virus egress and has been discussed to play a role
in assembly (Baines et al., 1995; Loomis et al., 2001). In
this study, the possibility of a function in early events could
not be excluded other than that the EHV-1 UL11 protein
appears not to be involved in virus penetration and that
infection and protein production were similarly effective
without expression of UL11 as judged by Western blot
analysis. If there then was an effect on early events of
infection, it would be minor in the systems analyzed at
present. Furthermore, deleting the UL11 protein did not
obviously obliterate any very late transport step in virus
egress, as one would then expect a clear reduction in extra-
cellular titers against intracellular infectivity. Generally, vi-
rus egress into the supernatant appeared to be relatively
effective, but a function in some transport processes, result-
ing in effective particle assembly and egress, is probable.
However, the most prominent phenotype observed was a
marked reduction in plaque size. Generally plaque size is
taken as a marker for efficient cell-to-cell spread. Of course
the cell-culture systems used often do not allow a clean
distinction between the mechanisms of direct cell-to-cell
spread and the mechanisms of infecting neighboring cells
via extracellular virions. That the reported general reduction
in virus yield of the UL11-deleted viruses might be exclu-
sively responsible for the small plaque phenotype though
can be excluded, as other mutant viruses that were tested on
the very same Rk13 cell system, such as EHV-1 deleted in
the early-late proteins UL45 or gM and gp2, do also repli-
cate at reduced levels, but do not exhibit any plaque phe-
notype (Oettler et al., 2001; Rudolph and Osterrieder,
2002). It is thus concluded that the EHV-1 UL11 protein
does somehow influence direct cell-to-cell spread. In this
context the observation that the ability of RacH to fuse
neighboring cells during infection was drastically re-
duced—if not lost—was very interesting. The phenomenon
of an effect on cell-to-cell spread and on fusion of cells
could be functionally connected. Mechanisms of direct cell-
to-cell spread are still relatively unknown, but could involve
directed and tightly regulated fusion of basolateral cellular
membranes (Johnson and Huber, 2002). Taking the as-
sumed localization of UL11 within infected cells into ac-
count, i.e., an orientation into the cytoplasm within the
proximity of specific cellular membranes, especially the
TGN, an indirect involvement of the UL11 protein in cell-
to-cell spread could be speculated on. It is suggested that
UL11 could direct or increase the efficiency of transport of
major participants—cellular or viral—to their final local-
ization, e.g., to specific areas of basolateral membranes.
Materials and methods
Plasmids
The complete UL11 ORF (gene 51) was amplified by
PCR, including recognition sites for KpnI and XhoI into
primer sequences, and the PCR product was then inserted
into vectors pcDNA3.1/Myc-His() and pcDNAI/Amp (In-
vitrogen), resulting in plasmids pC11myc and pC11. All
constructs were controlled by cycle sequencing (MWG Bio-
tech). To express a UL11-mycHis fusion protein in E. coli,
the sequences of the complete UL11-mycHis fusion gene
were released of pC11myc by an NcoI and PmeI digest and
cloned into vector pBADgIII (Invitrogen). Plasmid pBH3.1
carries the 2.9-kb EHV-1 BamHI-HindIII fragment, con-
taining UL11 encoding and adjacent sequences (Fig. 4B)
(Seyboldt et al., 2000) in vector pTZ18R (Stratagene). To
construct plasmid p11LacZ, 956 and 962 bp on either
side of the EHV-1 UL11 ORF were amplified by PCR,
using primers containing appropriate restriction enzyme
sites (recognition sites are in bold letters: 5-aagaattcgat-
gcgg tcaatgcttt-3 and 5-aaggtaccagggataccacttcgcc-3; 5-
atactgcagaaacgacgagaccccta-3and 5-gaaagcttcacaagcag-
gcagtcct-3; Fig. 4B). Both these fragments and a 3.8-kb E.
coli LacZ expression cassette that had been released of
vector pTT264A (Mettenleiter and Rauh, 1990) were se-
quentially cloned into vector pGem3Zf() (Promega), such
that the LacZ cassette was framed by viral sequences nec-
essary for homologous recombination. Due to overlapping
with the adjacent ORF UL12, UL11 nucleotides 1 to 73 had
to be left unaffected. Therefore plasmid p11LacZ aimed
at the deletion of the remaining 151 bp (67.4%) of UL11
sequences. To ensure correct termination of the UL12 to
UL14 transcripts, additional SV40 polyadenylation signal
sequences, taken via KpnI and PvuII from plasmid
pEGFP-C1 (Clontech; GenBank Accession No. U55763),
were introduced directly upstream of the inserted cassette
(into the respective KpnI and SmaI site, such that the ex-
pected transcripts were reduced by 48 nucleotides only)
(Fig. 4C).
Cells and viruses
Rk13 cells, equine dermal cell line Edmin337, and Cos7
cells were propagated in minimal essential medium supple-
mented with 5–10% fetal calf serum (Neubauer et al., 1997).
The EHV-1 UL11 expressing cell-line 51D3 was isolated
after transfection of Rk13 cells with plasmid pC11myc and
subsequent selection for Geniticin-resistant cell clones
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(G418, 500 g/ml, Calbiochem). Wild-type EHV-1 strain
RacL22 and its attenuated cell-culture derivative RacH (Hu¨-
bert et al., 1996) as well as the recombinant viruses gener-
ated in this study were grown and analyzed on the respec-
tive cell lines. To analyze phenotypes of un-infected and
infected cells, cells were embedded in ERL4206 as has been
described before (Neubauer et al., 2002) and semithin sec-
tions were stained with Toluidine blue.
Generation of recombinant viruses
The UL11-negative EHV-1, H11 and L11, were iso-
lated after homologous recombination in Rk13 cells. Super-
natants of cells, cotransfected with 5 g of plasmid
p11LacZ (Fig. 4C) and 1-2 g of DNA of either RacH
or RacL22, were plated onto monolayers of Rk13 cells and
single plaques of recombinant viruses were selected under
an agarose overlay (0.5%) containing 0.05% X-gal substrate
(Roche Molecular Biochemicals). Recombinant virus pop-
ulations were purified to homogeneity by four rounds of
plaque isolation. The UL11 repaired viruses, H11R and
L11R, were isolated accordingly after calcium phosphate
mediated cotransfection of plasmid pBH3.1 (Fig. 4B) with
DNA of H11 or L11 into Rk13 cells.
Southern blot analysis
Preparations of DNA from the respective viruses (Oster-
rieder et al., 1996) were subjected to restriction enzyme
analysis using EcoRV or HindIII. DNA fragments were
separated by 0.8% agarose gel electrophoresis and trans-
ferred onto positively charged nylon membranes, as previ-
ously described (Osterrieder et al., 1996; Neubauer et al.,
1997). UL11- and LacZ-specific sequences, as contained in
plasmids pBH3.1 or pTT264A, respectively, were labeled
with digoxigenin 11-dUTP according to the manufacturer’s
(Roche Molecular Biochemicals) instructions and used as
specific probes. DNA hybrids were detected using an anti-
digoxigenin alkaline phosphatase conjugate followed by
chemiluminescence detection (CSPD) (Roche Molecular
Biochemicals).
Purification of virions
Supernatants of infected cells (m.o.i. of 2) were cleared
by low-speed centrifugation (14 h p.i.). Extracellular virions
were purified of supernatants by repeated centrifugation
through a 30% sucrose cushion (Oettler et al., 2001).
Virion preparations were split into a fraction containing
proteins that become solubilized after treatment of virions
with 1% Triton X-100 in PBS (45°C for 20 min), i.e.,
proteins of the viral envelope and of the tegument, and
another fraction, representing capsids and adhering tegu-
ment proteins. Fractions were separated by centrifugation at
50,000 g for 30 min.
Fractionation of cells and analysis of protein synthesis
using phosphono acetic acid
Fractionation of cells was performed exactly as de-
scribed by Bogner et al. (1992). Infected Rk13 cells
(RacL22, m.o.i. of 3) were harvested 14 h p.i., washed with
PBS, and suspended in fractionation buffer (5 mM Na
phosphate, pH 7.5, 2 mM MgCl2, 0.5 mM CaCl2, 1 mM
PMSF). After freeze-thawing and ultrasonic treatment, su-
crose was added (ad 0.3 M) and nuclei and cell detritus were
pelleted by centrifugation at 800 g (10 min, pellet 1). The
resulting supernatant was cleared at 10,000 g (10 min) and
by another centrifugation step at 100,000 g (1 h, 4°C), a
fraction containing cellular membranes and vesicles of the
cell (pellet 2) and a fraction containing soluble components
of the cytoplasm (supernatant) were collected. Pellet 1 was
suspended in fractionation buffer followed by centrifugation
over a sucrose cushion to purify nuclei (1.62 M) that were
then lysed in fractionation buffer with 0.5% Triton X-100.
To inhibit synthesis of viral DNA, PAA was added to
Rk13 cells that were infected at an m.o.i. of 5 with RacL22,
at a concentration of 0.1, 0.5, or 1 mg per milliliter of
cell-culture medium. At 14 h p.i. cells were lysed and
analyzed by PAGE.
Western blotting and indirect immunofluorescence
Rk13 or Edmin337 cells, infected at an m.o.i. of 2-5 with
the respective viruses, were harvested at the indicated time
points p.i. The protein concentration of samples was ad-
justed to 1 mg/ml protein (BCA protein assay; Pierce)
before they were mixed with sample buffer (5% 2-mercap-
toethanol) (Sambrook et al., 1989), heated to 95°C for 5 min
or to 56°C for 2 min (for glycoprotein M detection only),
and separated on SDS–Tris–Glycine polyacrylamide gels
(PAGE; 12 or 15%). Alternatively, SDS–Tris–Tricine
16.5% PAGE was used to improve separation of low Mr
proteins, such as UL11 (Schagger and von Jagow, 1987). In
this case protein-adjusted lysates were mixed with sample
buffer, containing Tris–HCl (pH 6.8; 200 mM), glycerol
(40%), SDS (2%), and Coomassie blue G250 (0.04%) and
heated to 95°C for 5 min. After electrophoresis, proteins
were blotted onto nitrocellulose membranes and detected
exactly as described before (Oettler et al., 2001).
For IIF, cells grown on glass coverslips were either
infected with the indicated viruses or transfected with plas-
mids pC11 or pC11myc and fixed at the times given with
80% acetone. Unspecific binding was blocked with PBS
containing 10% FCS for 45 min. Cells were incubated with
the primary antibody for 30 min, and for another 30 min
with the anti-rabbit or anti-mouse IgG Alexa 546 or Alexa
488 conjugates (Molecular Probes). Processed samples
were analyzed and digitally documented using either an
Axiovert, an Axioscope, or an LSM510 laser scanning mi-
croscope (Zeiss, Oberkochen, Germany).
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Antibodies
The anti EHV-1-gB monoclonal antibody (mAb) 3F6
(Allen and Yeargan, 1987), anti EHV-1-gM mAb B8 (Day,
1999), the anti EHV-1-gD polyclonal anti-19mer rabbit
antibody (Flowers and O’Callaghan, 1992), anti EHV-1-gp2
mAb 3B12, anti EHV-1 gB mAb 4B6 (both Meyer and
Hu¨bert, 1988), anti-major-capsid protein mAb ZB4 (kindly
provided by G. B. Caughman), and the anti-UL34 antiserum
(Neubauer et al., 2002) were used in this study. A UL11-
specific antibody was generated by immunizing rabbits four
times in 4-week intervals with 50-100 g of a purified
UL11 protein. To this aim the complete UL11 ORF was
expressed in E. coli strain Top 10 as a mycHis fusion
protein using the pBADgIII expression system (Invitrogen).
The expressed protein was purified by affinity chromatog-
raphy followed by elution of SDS–polyacrylamide gels us-
ing an Electro-Eluter (Millipore). The quantity and quality
of the purified protein was confirmed by PAGE and by
Western blot analysis using an anti-6-His monoclonal anti-
body (Invitrogen). The anti -adaptin mAb was obtained
from Sigma Immunochemicals.
Virus growth kinetics and plaque size measurements
Rk13 cells in six-well plates were infected at 4°C with
the indicated viruses at an m.o.i. as stated. After 90 min of
absorption at 4°C, virus penetration was induced by shifting
the temperature to 37°C. The penetration period was
stopped after 90 min by inactivating remaining extracellular
virus with a citrate buffer (pH 3.0). At the indicated time
points supernatants and infected cells were collected sepa-
rately. Supernatants were cleared by low-speed centrifuga-
tion, whereas cells were again treated with citrate buffer to
inactivate adhering extracellular infectivity and subjected to
freeze-thawing. Virus titers were determined independently
on Rk13 cells. Plaque sizes of the different viruses on Rk13
cells or 51D3 cells (50 PFU/six-well) were measured after 3
days under a 0.25% methylcellulose overlay. Maximum
diameters of 150 randomly selected plaques were deter-
mined using a magnifying glass with a metric scale. Se-
lected plaques were stained by IIF and visualized in an
Axiovert microscope (Zeiss); pictures were taken, scanned,
and digitally processed.
Penetration assays
Penetration assays were performed as previously de-
scribed (Neubauer et al., 1997). Briefly, 100 PFU of the
respective viruses were allowed to adsorb for 90 min to
Rk13 cells grown on six-well plates. The assay was started
by shifting the incubation temperature to 37°C and at dif-
ferent times after the temperature shift, extracellular virus
was inactivated using a citrate buffer (pH 3.0). The pene-
tration effectivity was determined by comparing the number
of plaques present after citrate treatment with the number of
plaques present after control treatment (PBS).
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